CFO
GMED icon

CVA Family Office’s Globus Medical GMED Stock Holding History

CVA Family Office’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.74K Sell
60
-10
-14% -$850 ﹤0.01% 1290
2026
Q1 		$6.03K Buy
70
+62
+775% +$5.57K ﹤0.01% 1165
2025
Q4 		$698 Buy
+8
New +$607 ﹤0.01% 1160
2025
Q2 		– Sell
-7
Closed -$512 – 1346
2025
Q1 		$512 Buy
+7
New +$578 ﹤0.01% 1261
2022
Q4 		– Sell
-5
Closed – – 972
2022
Q3 		$0 Hold
5
– – ﹤0.01% 895
2022
Q2 		$0 Hold
5
– – ﹤0.01% 932
2022
Q1 		$0 Buy
+5
New +$348 ﹤0.01% 965

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

CVA Family Office's GMED Position: Q2 2026 in Review

CVA Family Office reduced its Globus Medical (GMED) stake by 14% in Q2 2026, selling an estimated $850 and leaving 60 shares worth $4.74K. The position accounts for ﹤0.01% of the portfolio, ranked #1290.

CVA Family Office first reported a position in GMED in Q1 2022 and has held it in 7 quarters since. The position peaked at $6.03K in Q1 2026. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • CVA Family Office held 60 shares of Globus Medical worth $4.74K as of Q2 2026.
  • CVA Family Office sold 10 Globus Medical shares in Q2 2026, an estimated $850.
  • Globus Medical made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1290 holding.
  • CVA Family Office first reported a position in Globus Medical in Q1 2022 and has held it in 7 quarters since.
  • CVA Family Office's Globus Medical position peaked at $6.03K in Q1 2026.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.